- •Isolation precautions demand spending of a large amount of resources.
- •Multidrug-resistant gram-negative bacteria are the biggest challenge in our setting.
- •Benefits of screening and isolation must be balanced against resource utilization.
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to American Journal of Infection Control
- 2007 guideline for isolation precautions: preventing transmission of infectious agents in health care settings.Am J Infect Control. 2007; 35: S65-S164
- Isolation of NDM-producing Providencia rettgeri in Brazil.J Antimicrob Chemother. 2013; 68: 2956-2957
- Carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme: dissemination in Southern Brazil.Infection. 2009; 37: 474-476
- The challenges of antimicrobial resistance in Brazil.Clin Infect Dis. 2011; 52: 1138-1143
- Detection of OXA-370, an OXA-48-Related class D beta-lactamase, in Enterobacter hormaechei from Brazil.Antimicrob Agents Chemother. 2014; 58: 3566-3567
- SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus.Infect Control Hosp Epidemiol. 2003; 24: 362-386
- Management of multidrug-resistant organisms in health care settings, 2006.Am J Infect Control. 2007; 35: S165-S193
- Adverse effects of isolation in hospitalised patients: a systematic review.J Hosp Infect. 2010; 76: 97-102
- Impact of contact isolation for multidrug-resistant organisms on the occurrence of medical errors and adverse events.Intensive Care Med. 2013; 39: 2153-2160
- Interventions to reduce colonisation and transmission of antimicrobial-resistant bacteria in intensive care units: an interrupted time series study and cluster randomised trial.Lancet Infect Dis. 2014; 14: 31-39
Funding/support: This research was supported through an operational research course, which was jointly developed and run by the Centre for Operational Research, International Union Against Tuberculosis and Lung Disease, and Operational Research Unit, Medecins sans Frontieres, Brussels. The course was supported financially by an anonymous donor and the Department for International Development, UK.
Conflicts of interest: None declared.